Carolina Q. Sacramento

Author

Also Known As

C.Q. Sacramento, Carolina Q Sacramento, Carolina Q. Sacramento, Carolina Sacramento, Carolina de Queiroz Sacramento, Lane, Thomas R., Puhl, Ana C., Sacramento, Carolina Q.

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Universidade Federal do Rio de Janeiro D’Or Institute for Research and Education Universidade Iguaçu Universidade Federal de Juiz de Fora

About

Carolina Q. Sacramento is an author at Fundação Oswaldo Cruz specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	516
2	Cell Biology	4	4	134
3	Engineering	1	1	34
4	Biochemistry	1	1	34
5	Biomolecular Engineering	1	1	34

Carolina Q. Sacramento

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators Suelen da Silva Gomes Dias, Vinícius Cardoso Soares, André C. Ferreira, PLoS Pathogens	2020	298
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, Cell Death Discovery	2021	270
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication Carolina Q. Sacramento, Gabrielle R. de Melo, Caroline S. de Freitas, Scientific Reports	2017	236
Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs M.De L. Ferreira, Luiz C. S. Pinheiro, Osvaldo A. Santos‐Filho, Medicinal Chemistry Research Antiviral ActivityMedicineAntiviral Drug DevelopmentAntiviral TherapyVirology	2013	140
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production Natalia Fintelman‐Rodrigues, Carolina Q. Sacramento, Carlyle Ribeiro Lima, Antimicrobial Agents and Chemotherapy	2020	138
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo Caroline S. de Freitas, Luiza M. Higa, Carolina Q. Sacramento, PLoS neglected tropical diseases	2019	119
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae André C. Ferreira, Camila Zaverucha-do-Valle, Patrícia A. Reis, Scientific Reports	2017	110
<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo, Journal of Antimicrobial Chemotherapy	2021	98
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication André C. Ferreira, Patrícia A. Reis, Caroline S. de Freitas, Antimicrobial Agents and Chemotherapy	2018	93
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, ACS Omega	2021	73

Page 1